MAY 29, 2014 6:00 AM PDT

Chronic Pain Management and Laboratory Testing

Speaker
  • Anesthesiology/Chronic Pain Management, Cleveland Clinic
    Biography
      Dr. Abraham is a staff anesthesiologist at the Cleveland Clinic Foundation.  He specializes in the management of chronic pain, with a focus on multimodal treatment techniques.   This began with an interest in neuroscience, for which he received his Bachelors of Science at Johns Hopkins University.  His diverse interests in confocal microscopy, peptide processing, and nerve regeneration led to multiple awards and peer-reviewed publications.  After earning his medical degree from the State University of New York, he completed his training in General Anesthesiology and fellowship training in Interventional Pain Management at the Cleveland Clinic Foundation.    

    Abstract

    Chronic pain has continued to grow as a public health concern, now affecting more than 116 million people in the United States. It is the leading cause of disability among American workers. Laboratory testing has become increasingly important in order to care for these patients safely.

    This presentation will review the history and new challenges for treatment inherent in this population


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources